Welcome to our dedicated page for Atlanta Braves Holdings SEC filings (Ticker: BATRB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Atlanta Braves Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Atlanta Braves Holdings's regulatory disclosures and financial reporting.
Atlanta Braves Holdings investor John C. Malone filed an amended Schedule 13D showing he now beneficially holds a majority of the company’s voting power. He owns 557,039 shares of Series A common stock (about 5.4% of that class) and 949,201 shares of Series B common stock (about 97.1% of that class), giving him approximately 50.01% of the voting power in director elections.
Recent purchases include 4,631 and 2,259 Series A shares in November 2025 at prices around $42, 3,669 Series B shares on February 4, 2026 at $48.17, and 35,000 Series A shares on February 5, 2026 at a volume-weighted average price of $44.23. Because he now holds a voting majority, the company will be deemed a “Controlled Company” under Nasdaq rules, and Malone can exert significant influence over the board, major transactions, and other matters requiring shareholder approval.
Atlanta Braves Holdings, Inc. investor John C. Malone has updated his ownership, reporting beneficial control of about 50.01% of the company’s voting power in director elections through Series A and high‑vote Series B common stock.
He directly and indirectly holds 557,039 shares of Series A Common Stock, or about 5.4% of that class, and 949,201 shares of Series B Common Stock, or about 97.1% of that class, based on the share counts outstanding as of October 31, 2025. Recent purchases include multiple open‑market buys of Series A between $41.96 and $44.74 per share and a privately negotiated Series B purchase at $48.17 per share.
Because Malone now beneficially holds more than a majority of the outstanding voting securities, Atlanta Braves Holdings will be deemed a “Controlled Company” under Nasdaq rules, giving him significant influence over the board, major transactions and other matters requiring shareholder approval, subject to Major League Baseball rules and existing voting agreements.
Atlanta Braves Holdings executive Jill L. Robinson exercised stock options and sold shares of Series C Common Stock. On 02/02/2026, she exercised options for 20,000 BATRK shares at an exercise price of $27.18 per share and received 20,000 shares.
That same day, she sold 20,000 Series C Common shares at a weighted average price of $40.00 per share, within a range of $39.71 to $40.22, under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2025. After these transactions, she directly owned 79,460 Series C Common shares and held 90,263 stock options.
A shareholder of BATRA, identified as Jill Robinson, has filed a Form 144 indicating an intention to sell 20,000 shares of Series C Common Stock through UBS Financial Services on NASDAQ at an aggregate market value of $800,028.
The shares are scheduled for approximate sale on February 2, 2026 and were acquired the same day via a cash exercise of stock options for 20,000 shares. The issuer had 51,627,382 shares outstanding of the same class at the time referenced. Robinson also sold Series C Common shares in three prior transactions over the past three months, with individual sales of 20,000, 6,875 and 3,830 shares.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 733,932 shares of Atlanta Braves Holdings Inc common stock, representing 7.11% of the class as of the event date of 12/31/2025.
Vanguard reports shared voting power over 144,675 shares and shared dispositive power over all 733,932 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The filing also notes that on 01/12/2026 Vanguard underwent an internal realignment, after which certain subsidiaries or business divisions with beneficial ownership will report on a disaggregated basis. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends or sale proceeds, but no single other person has more than a 5% interest in these securities.
The Vanguard Group reported beneficial ownership of 2,789,081 shares of Atlanta Braves Holdings Inc. common stock, representing 5.4% of the class as of the event date 12/31/2025.
Vanguard reports shared voting power over 326,604 shares and shared dispositive power over all 2,789,081 shares, with no sole voting or dispositive power. The shares are held on behalf of Vanguard’s clients, none of whom individually owns more than 5% of the class. Vanguard notes an internal realignment effective 01/12/2026, after which certain subsidiaries are expected to report beneficial ownership separately.